Nicola Fusco

Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab.

Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.

Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.

Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up.

Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma.

Tackling the diversity of breast cancer related lymphedema: Perspectives on diagnosis, risk assessment, and clinical management.

Alterations are Linked to Increased HER2 Expression in Breast Cancer-Letter.

Diagnostic challenge of intrathoracic tissue misplacements: a thymic choristoma in a fetal lung.

Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers.

Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study.

RE: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.

Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From and Studies.

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record.

Cellular immunotherapy in breast cancer: The quest for consistent biomarkers.

Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients.

Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients.

Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization.

Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study.

Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.

Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates.

Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.

Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling.

Low-risk triple-negative breast cancers: Clinico-pathological and molecular features.

Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer.

Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles.